OTCM
AJOY
, Last price
USD
Name
Ayujoy Herbals Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ayujoy Herbals Ltd. operates as a specialized research and testing organization, providing expert technical and regulatory consulting services. Their focus encompasses a wide array of products, including biotechnological innovations, pharmaceuticals, diagnostic instruments, and various medical equipment and devices. The company's primary clientele consists of pharmaceutical enterprises throughout India and Southeast Asia. Ayujoy Herbals' core objective is to assist these clients in navigating the complex process of securing FDA approval, thereby facilitating the export of their pharmaceutical, medical products, and devices to the United States market. Their extensive service portfolio covers essential aspects such as analytical quality control (QC) and quality assurance (QA) functions, preparation for regulatory inspections, and ensuring broad compliance. This also includes comprehensive validation services, clinical trial management, and professional guidance on regulatory and legal affairs. Specifically, they handle the meticulous preparation of regulatory filings, conduct compliance and risk assessments, and perform mock FDA audits. Additionally, Ayujoy Herbals offers specialized support for medical devices and Chemistry, Manufacturing, and Controls (CMC), provides Good Manufacturing Practice (GMP) training, and offers consulting for facility layout. The firm also expertly manages validation for utilities, processes, IT systems, computer systems, and cleaning procedures. Established in 2008, the company is headquartered in Mumbai, India.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2018‑06 | 2017‑06 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT |